• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 前のページに戻る

Exploring the exosome-nanosome combinatorial platform as a novel, universal, and ideal nanoparticle-based drug delivery system

研究課題

研究課題/領域番号 22K20705
研究種目

研究活動スタート支援

配分区分基金
審査区分 0801:薬学およびその関連分野
研究機関北海道大学

研究代表者

タン ロジャー・サルバシオン  北海道大学, 先端生命科学研究院, 助教 (10951759)

研究期間 (年度) 2022-08-31 – 2024-03-31
研究課題ステータス 中途終了 (2023年度)
配分額 *注記
2,860千円 (直接経費: 2,200千円、間接経費: 660千円)
2023年度: 1,430千円 (直接経費: 1,100千円、間接経費: 330千円)
2022年度: 1,430千円 (直接経費: 1,100千円、間接経費: 330千円)
キーワードExosome / Nanosome / Drug Delivery System / Nanoparticles / Exosome-nanosme / Cancer cells / Nanoparticle
研究開始時の研究の概要

Part 1: Exosome target organ determination.
Part 2: Nanosome construction and Drug loading.
Part 3: Efficiency testing of the novel platform.

研究実績の概要

In the extracellular vesicles population produced by cells, exosomes only constitute a small portion of the population. This has been one of the limitations of studying exosomes. One of the optimization protocols necessary and employed in this research was to find a way to induce the production of a higher number of exosomes in cancer cells. After employing different strategies, we were able to successfully induce cancer cells to produce a higher number of exosomes by starving them. Production and isolation of exosomes from starved cancer cells were then optimized to yield a stably high number of exosomes. Starved cancer cells produced a higher number of exosomes (1.56e+15 particles per mL with an average particle size of 139.5 nm) compared to the fed cancer cells (1.51e+10 particles per mL with an average particle size of 106.5 nm). This finding enabled us to optimize the exosome production and yielded considerably more exosomes needed for the study.

報告書

(2件)
  • 2023 実績報告書
  • 2022 実施状況報告書

URL: 

公開日: 2022-09-01   更新日: 2024-12-25  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi